STAQ Pharma is a hospital-owned 503B outsourcing partner dedicated to supplying critical medications to healthcare systems with a focus on safety, transparency, availability, and quality. With two FDA-registered facilities, STAQ Pharma manufactures sterile medications to help alleviate drug shortages and support exceptional patient care. The portfolio includes IV bags and syringes designed for efficiency and reliability, ensuring healthcare providers have access to the medications their patients need. By prioritizing quality and compliance, STAQ Pharma enables hospitals and healthcare systems to navigate supply challenges and deliver life-saving treatments with confidence. Through partnerships with organizations like Angels for Change and the Hemophilia Alliance, STAQ Pharma plays a key role in mitigating critical shortages. As one of the first 503B outsourcing facilities to manufacture critical oncology medications like Methotrexate, STAQ Pharma is actively addressing the cancer drug shortage crisis to ensure reliable access to life-saving treatments. With a commitment to proactive inventory management and high-quality manufacturing, STAQ Pharma continues to expand its impact in the 503B outsourcing space.